Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation.

Perez-Daga JA, Santoyo J, Suárez MA, Fernández-Aguilar JA, Ramírez C, Rodríguez-Cañete A, Aranda JM, Sánchez-Pérez B, Montiel C, Palomo D, Ruiz M, Mate A.

Transplant Proc. 2006 Oct;38(8):2468-70.

PMID:
17097969
2.

Use of severely steatotic grafts in liver transplantation: a matched case-control study.

McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA.

Ann Surg. 2007 Dec;246(6):940-6; discussion 946-8.

PMID:
18043095
3.

Does donor's fatty liver change impact on early mortality and outcome of liver transplantation.

Nikeghbalian S, Nejatollahi SM, Salahi H, Bahador A, Sabet B, Jalaeian H, Geramizadeh B, Dehghani SM, Malek-Hosseini SA.

Transplant Proc. 2007 May;39(4):1181-3.

PMID:
17524926
4.

Use of steatotic graft in living-donor liver transplantation.

Soejima Y, Shimada M, Suehiro T, Kishikawa K, Yoshizumi T, Hashimoto K, Minagawa R, Hiroshige S, Terashi T, Ninomiya M, Shiotani S, Harada N, Sugimachi K.

Transplantation. 2003 Jul 27;76(2):344-8.

PMID:
12883190
5.

Effect of graft steatosis on liver function and organ survival after liver transplantation.

Angele MK, Rentsch M, Hartl WH, Wittmann B, Graeb C, Jauch KW, Loehe F.

Am J Surg. 2008 Feb;195(2):214-20.

PMID:
18154767
6.

Impact of donor, recipient, and graft features on the development of primary dysfunction in liver transplants.

Fernández-Merino FJ, Nuño-Garza J, López-Hervás P, López-Buenadicha A, Moreno-Caparrós A, Quijano-Collazo Y, Sanjuanbenito A, Vicente-López E.

Transplant Proc. 2003 Aug;35(5):1793-4.

PMID:
12962797
7.

Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.

Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, Stewart G, McCaughan G.

Liver Transpl. 2003 May;9(5):500-5.

8.

Reversal of graft steatosis after liver transplantation: prospective study.

Li J, Liu B, Yan LN, Zuo YX, Li B, Zeng Y, Zhang SF, Li FG.

Transplant Proc. 2009 Nov;41(9):3560-3. doi: 10.1016/j.transproceed.2009.06.222.

PMID:
19917344
9.

The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.

Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM.

J Viral Hepat. 2009 Jul;16(7):492-9. doi: 10.1111/j.1365-2893.2009.01098.x. Epub 2009 Feb 5.

PMID:
19200134
10.

Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired.

Cho JY, Suh KS, Kwon CH, Yi NJ, Lee KU.

Surgery. 2006 Apr;139(4):508-15.

PMID:
16627060
11.

Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters.

Cieślak B, Lewandowski Z, Urban M, Ziarkiewicz-Wróblewska B, Krawczyk M.

Transplant Proc. 2009 Oct;41(8):2985-8. doi: 10.1016/j.transproceed.2009.08.019.

PMID:
19857657
12.

Influence of ischemia and surgery times on development of primary dysfunction liver transplant in patients.

Fernández-Merino J, Nuño-Garza J, López-Hervás P, López-Buenadicha A, Quijano-Collazo Y, Vicente-López E.

Transplant Proc. 2003 Jun;35(4):1439-41.

PMID:
12826184
13.

Biological changes after liver transplantation according to the presence or not of graft steatosis.

Muscari F, Guinard JP, Foppa B, Trocard P, Danjoux M, Kamel MS, Duffas JP, Rostaing L, Fourtanier G, Suc B.

Transplant Proc. 2008 Dec;40(10):3562-5. doi: 10.1016/j.transproceed.2008.06.087.

PMID:
19100438
14.

Donor liver dysfunction: application of a new scoring system to identify the marginal donor.

Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, Fonseca LE, Motta TD, Pandullo FL, Rezende MB, Meira-Filho SP, Sá JR, Afonso RC.

Transplant Proc. 2007 Oct;39(8):2516-8.

PMID:
17954162
15.

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.

Liver Transpl. 2009 Jun;15(6):619-28. doi: 10.1002/lt.21761.

16.

Noninvasive evaluation of graft steatosis in living donor liver transplantation.

Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, Fujii K, Kiuchi T, Tanaka K.

Transplantation. 2004 Nov 27;78(10):1501-5.

PMID:
15599315
17.

Expanding postmortem donor pool using steatotic liver grafts: a new look.

Noujaim HM, de Ville de Goyet J, Montero EF, Ribeiro CM, Capellozzi VL, Crescentini F, Casagrande M, Santos RG, Curvello L, de Miranda MP, Genzini T.

Transplantation. 2009 Mar 27;87(6):919-25. doi: 10.1097/TP.0b013e31819b3f76.

PMID:
19300197
18.

Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.

de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ.

J Gastroenterol Hepatol. 2012 Mar;27(3):540-6. doi: 10.1111/j.1440-1746.2011.06844.x.

PMID:
21777274
19.

Fatty liver in liver transplantation and surgery.

Selzner M, Clavien PA.

Semin Liver Dis. 2001;21(1):105-13. Review.

PMID:
11296690
20.

Hepatic neutrophil activation during reperfusion may not contribute to initial graft function after short cold ischemia in human liver transplantation.

Ilmakunnas M, Höckerstedt K, Mäkisalo H, Siitonen S, Repo H, Pesonen EJ.

Transplant Proc. 2009 Mar;41(2):739-42. doi: 10.1016/j.transproceed.2009.01.034.

PMID:
19328969

Supplemental Content

Support Center